2.160USD-1.64%Mkt Cap: 2.22M USDP/E: —Last update: 2026-06-01
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measureme…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap2.22M USD
Enterprise Value-1.37M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-6.85M USD
Revenue/Share—
Last Price2.160 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.69
PEG—
EV/EBITDA0.20
EV/Revenue—
P/S—
P/B0.53
EPS (TTM)-3.74
EPS (Forward)-0.32
52W Range
1.6234% of range16.68
52W High16.68 USD
52W Low1.623 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-114.61%
ROA-96.20%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.05M USD
CapEx (TTM)173.74K USD
FCF Margin—
FCF Yield-184.77%
Net Debt-3.59M USD
Net Debt/EBITDA0.52
Balance Sheet
Debt/Equity0.02
Current Ratio2.81
Quick Ratio2.61
Book Value/Sh4.041 USD
Cash/Share3.561 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJan 29, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.03M
Float844.45K
Insiders11.22%
Institutions10.62%
Short Interest
Short Ratio0.3d
Short % Float0.70%
Short % Out.0.65%
Shares Short6.76K
Short (prev mo.)17.26K
Technical
SMA 501.893 (+14.1%)
SMA 2004.243 (-49.1%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)37.54K
Avg Vol (10d)90.10K
Technical Indicators
RSI (14)68.0
MACD0.0396
MACD Signal-0.0108
MACD Hist.+0.0504
BB Upper2.136 USD
BB Middle1.861 USD
BB Lower1.586 USD
BB Width29.57%
ATR (14)0.1462 USD
Vol Ratio (20d)2.22x